Published in J Virol on June 11, 2008
Widely conserved recombination patterns among single-stranded DNA viruses. J Virol (2008) 1.78
Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV. Vet Immunol Immunopathol (2009) 0.93
Novel gammaherpesviruses in North American domestic cats, bobcats, and pumas: identification, prevalence, and risk factors. J Virol (2014) 0.90
Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation. J Virol (2014) 0.90
Distribution of the phenotypic effects of random homologous recombination between two virus species. PLoS Pathog (2011) 0.86
Molecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus). Vet Immunol Immunopathol (2009) 0.83
Pathogenicity and rapid growth kinetics of feline immunodeficiency virus are linked to 3' elements. PLoS One (2011) 0.81
FIV diversity: FIV Ple subtype composition may influence disease outcome in African lions. Vet Immunol Immunopathol (2011) 0.80
Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection. J Neurovirol (2011) 0.80
Accessory genes confer a high replication rate to virulent feline immunodeficiency virus. J Virol (2013) 0.77
Strain-specific viral distribution and neuropathology of feline immunodeficiency virus. Vet Immunol Immunopathol (2011) 0.77
Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virus. PLoS One (2014) 0.76
Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection. J Immunol Methods (2013) 0.75
First Molecular Characterization of Feline Immunodeficiency Virus in Domestic Cats from Mainland China. PLoS One (2017) 0.75
Feline models of viral pathogenesis: opportunity knocks. Vet J (2010) 0.75
Pathogenesis of oral FIV infection. PLoS One (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature (2004) 17.56
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A (2004) 5.15
Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 4.57
Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci U S A (1995) 3.23
Comparison of two host cell range variants of feline immunodeficiency virus. J Virol (1990) 2.98
Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc (1989) 2.97
Persistent infection of macaques with simian-human immunodeficiency viruses. J Virol (1995) 2.22
Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc (1989) 2.13
Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol (1997) 2.08
In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol (1993) 2.00
Feline immunodeficiency virus infection. Vet Immunol Immunopathol (1989) 2.00
Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science (2004) 1.93
Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 1.92
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol (1998) 1.79
Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins. J Virol (2005) 1.71
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol (1994) 1.59
Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol (2001) 1.54
Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis (1994) 1.53
Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. J Virol (1991) 1.49
Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species. J Virol (2005) 1.47
Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A (2004) 1.38
Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J Virol (1995) 1.28
Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J Virol (1999) 1.20
Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate. J Virol (1991) 1.19
Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats. Vet Immunol Immunopathol (2001) 1.18
Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J Virol (1999) 1.18
Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J Virol (2004) 1.14
Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus. J Virol (2006) 1.07
Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity. J Virol (2005) 1.04
Multiple restrictions of human immunodeficiency virus type 1 in feline cells. J Virol (2007) 1.00
FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation. Vet Immunol Immunopathol (1998) 0.98
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology (2004) 0.97
Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat. J Gen Virol (1994) 0.97
Differential cell tropism of feline immunodeficiency virus molecular clones in vivo. J Virol (1999) 0.97
Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci U S A (1994) 0.95
Characterization of less pathogenic infectious molecular clones derived from acute-pathogenic SHIV-89.6p stock virus. Virology (2001) 0.92
Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3. J Virol (2004) 0.87
Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res Hum Retroviruses (2000) 0.87
Inhibitors of HIV-1 protease by using in situ click chemistry. Angew Chem Int Ed Engl (2006) 1.63
Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species. J Virol (2005) 1.47
Effects and limitations of an AED with audiovisual feedback for cardiopulmonary resuscitation: a randomized manikin study. Resuscitation (2011) 1.42
Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A (2004) 1.38
Conformational flexibility in the flap domains of ligand-free HIV protease. Acta Crystallogr D Biol Crystallogr (2007) 1.36
Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood (2004) 1.34
Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. Blood (2004) 1.32
Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. J Clin Invest (2003) 1.27
1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. Chembiochem (2005) 1.27
Species-specific assessment of pain in laboratory animals. Contemp Top Lab Anim Sci (2003) 1.26
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J Biol Chem (2005) 1.23
RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci U S A (2011) 1.19
Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat Struct Mol Biol (2004) 1.16
Three pathogens in sympatric populations of pumas, bobcats, and domestic cats: implications for infectious disease transmission. PLoS One (2012) 1.15
Is resistance futile? Curr Drug Targets Infect Disord (2003) 1.14
Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J Virol (2004) 1.14
Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors. Chembiochem (2003) 1.13
Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J Immunol (2008) 1.13
Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnol J (2007) 1.09
Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120. Retrovirology (2006) 1.08
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J Virol (2006) 1.08
Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN. J Virol (2004) 1.07
Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J Virol (2004) 1.05
Assessing flavivirus, lentivirus, and herpesvirus exposure in free-ranging ring-tailed lemurs in southwestern Madagascar. J Wildl Dis (2007) 1.04
Prevention of immunodeficiency virus induced CD4+ T-cell depletion by prior infection with a non-pathogenic virus. Virology (2008) 1.04
Molecular mechanisms of FIV infection. Vet Immunol Immunopathol (2008) 1.02
Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells. Mol Ther (2004) 1.01
Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators. J Virol (2002) 1.00
Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains. J Virol (2007) 1.00
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology (2004) 0.97
Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases. J Virol (2003) 0.97
Genomic organization, sequence divergence, and recombination of feline immunodeficiency virus from lions in the wild. BMC Genomics (2008) 0.96
Small molecule regulation of protein conformation by binding in the Flap of HIV protease. ACS Chem Biol (2013) 0.94
Neurologic disease in captive lions (Panthera leo) with low-titer lion lentivirus infection. J Clin Microbiol (2006) 0.93
Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3. J Mol Biol (2005) 0.93
A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. J Med Chem (2008) 0.92
Defining HIV-1 protease substrate selectivity. Curr Drug Targets Infect Disord (2002) 0.91
Distribution and prevalence of Cytauxzoon felis in bobcats (Lynx rufus), the natural reservoir, and other wild felids in thirteen states. Vet Parasitol (2010) 0.91
Novel gammaherpesviruses in North American domestic cats, bobcats, and pumas: identification, prevalence, and risk factors. J Virol (2014) 0.90
Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol (2008) 0.89
Crystallographic fragment-based drug discovery: use of a brominated fragment library targeting HIV protease. Chem Biol Drug Des (2013) 0.88
Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. Virology (2007) 0.88
Feline lentiviruses demonstrate differences in receptor repertoire and envelope structural elements. Virology (2005) 0.87
Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3. J Virol (2004) 0.87
Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system. J Virol (2006) 0.87
Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3. Retrovirology (2007) 0.87
Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries. Biochem J (2010) 0.87
Molecular determinants of HIV-1 subtype C coreceptor transition from R5 to R5X4. Virology (2010) 0.86
Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein. PLoS One (2010) 0.85
Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol (2011) 0.85
A twin-cysteine motif in the V2 region of gp120 is associated with SIV envelope trimer stabilization. PLoS One (2013) 0.83
Recombination in feline lentiviral genomes during experimental cross-species infection. Virology (2006) 0.82
Pathogenicity and rapid growth kinetics of feline immunodeficiency virus are linked to 3' elements. PLoS One (2011) 0.81
Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease. J Virol (2010) 0.81
Direct comparison of steady-state marrow, primed marrow, and mobilized peripheral blood for transduction of hematopoietic stem cells in dogs. Hum Gene Ther (2003) 0.81
Animal models for HIV AIDS: a comparative review. Comp Med (2007) 0.81
OrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection. J Virol (2010) 0.80
Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats. Neurosci Lett (2005) 0.80
Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection. J Neurovirol (2011) 0.80
FIV associated neoplasms--a mini-review. Vet Immunol Immunopathol (2011) 0.80
Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases. Bioorg Med Chem (2003) 0.80
Multivariate statistical analyses demonstrate unique host immune responses to single and dual lentiviral infection. PLoS One (2009) 0.80
The effects of urbanization on population density, occupancy, and detection probability of wild felids. Ecol Appl (2015) 0.79
Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134. Proc Natl Acad Sci U S A (2009) 0.79
Characterization of regionally associated feline immunodeficiency virus (FIV) in bobcats (Lynx rufus). J Wildl Dis (2013) 0.79
Ocelots on Barro Colorado Island are infected with feline immunodeficiency virus but not other common feline and canine viruses. J Wildl Dis (2008) 0.79
Epoxide opening in water and screening in situ for rapid discovery of enzyme inhibitors in microtiter plates. Bioorg Med Chem (2005) 0.78
High Fungal Spore Load in Corncob Bedding Associated with Fungal-Induced Rhinitis in Two Rats. Contemp Top Lab Anim Sci (1999) 0.78
Prior virus exposure alters the long-term landscape of viral replication during feline lentiviral infection. Viruses (2011) 0.78
Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease. Acta Crystallogr D Biol Crystallogr (2011) 0.78
Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection. Retrovirology (Auckl) (2012) 0.77
Sudden onset of mortality within a colony of FVB/n mice. Lab Anim (NY) (2007) 0.77
Accessory genes confer a high replication rate to virulent feline immunodeficiency virus. J Virol (2013) 0.77
Partial regulatory T cell depletion prior to acute feline immunodeficiency virus infection does not alter disease pathogenesis. PLoS One (2011) 0.77
Selection of drug-resistant feline immunodeficiency virus (FIV) encoding FIV/HIV chimeric protease in the presence of HIV-specific protease inhibitors. J Virol (2013) 0.75
Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection. J Immunol Methods (2013) 0.75
Prolonged waking reduces human immunodeficiency virus glycoprotein 120- or tumor necrosis factor alpha-induced apoptosis in the cerebral cortex of rats. Neurosci Lett (2004) 0.75